Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas

Lin Qi1,2, Ruiling Xu1,2, Xiaolei Ren1,2

  • 1Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, China.

Insights

This study identifies necroptosis-related genes (NRGs) as potential biomarkers for soft tissue sarcomas (STSs). A novel NRG-based risk score effectively predicts patient prognosis and immune infiltration in STSs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Soft tissue sarcomas (STSs) are rare, heterogeneous cancers posing significant therapeutic challenges.
  • Limited chemotherapy response and rarity necessitate novel treatment strategies.
  • Necroptosis, a regulated cell death pathway, is emerging as a key factor in cancer immunotherapy.

Purpose of the Study:

  • To investigate the role of necroptosis-related genes (NRGs) in soft tissue sarcomas (STSs).
  • To identify NRGs that can serve as prognostic biomarkers for STSs.
  • To explore the relationship between NRGs, prognosis, and immune infiltration in STSs.

Main Methods:

  • Utilized The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) projects to identify differentially expressed NRGs.
  • Employed consensus cluster analysis to stratify STS patients into prognostic groups.
  • Developed a 10-gene necroptosis-related risk score and validated it using external datasets and a nomogram.

Main Results:

  • Identified significant differences in 34 NRGs between STS and normal tissues.
  • Established two distinct STS clusters with significant survival differences (p=0.002).
  • The 10-gene necroptosis-related risk score accurately predicted prognosis (p<0.001) and correlated with increased immune infiltration in TCGA-SARC cohort.

Conclusions:

  • Necroptosis-related gene signatures are crucial prognostic indicators for STSs.
  • The developed risk score demonstrates potential for predicting STS patient outcomes and guiding immunotherapy.
  • Necroptosis-related genes may serve as prognostic markers across various cancer types, warranting further investigation.